ESTUTC-5 New YorkLog in Sign up

CCCC
C4 Therapeutics, Inc.
stockNASDAQ

Market OpenNov 12, 2026 9:44:48 AM EST

2.77USD-4.152%(-0.12)92,485

Pre-marketNov 12, 2026 9:21:30 AM EST

2.85USD-1.384%(-0.04)

2.7600Bid2.7800Ask0.0200Spread

CCCC News

Day breaks

03:19 PM ESTC4 Therapeutics at guggenheim healthcare innovation: cemsidomide push ·

Investing.com

12:02 PM ESTCCCC Maintained by Guggenheim -- Price Target Lowered to $6.00 ·

GuruFocus

07:25 AM ESTC4 Therapeutics GAAP EPS of -$0.16 beats by $0.04, revenue of $8.4M misses by $0.12M ·

Seeking Alpha

07:00 AM ESTC4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights ·

GlobeNewswire Inc.

10:15 AM ESTShort Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October ·

Seeking Alpha

07:00 AM ESTC4 Therapeutics to Participate in Upcoming November Investor Conferences ·

GlobeNewswire Inc.

04:01 PM ESTC4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.

07:20 AM EDTC4 Therapeutics unveils DEL technology for drug discovery ·

Investing.com

07:00 AM EDTC4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders ·

GlobeNewswire Inc.

11:20 AM EDTChina Imposes Export Curbs On Drones, Heavy Machinery ·

Zero Hedge

04:08 AM EDTJPMorgan initiates C4 Therapeutics stock coverage at Overweight ·

Investing.com

03:00 PM EDTCatalyst Watch: Microsoft event, FOMC talk, and the finish line for Paramount-Warner Bros. ·

Seeking Alpha

10:15 AM EDTShort Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 ·

Seeking Alpha

07:04 AM EDTC4 Therapeutics presents cemsidomide trial biomarker data ·

Investing.com

07:00 AM EDTC4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting ·

GlobeNewswire Inc.

07:01 AM EDTConstruction firm deploys equipment, rescues four from Enugu building collapse ·

BusinessDay